The Effects of Mindfulness-Based Interventions in People with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Mo Yi, Wenmin Zhang, Baosheng Zhao, Zhiwen Wang
Clinical gerontologist January 1, 2025 DOI: 10.1080/07317115.2024.2314192 via PubMed
Summary
AI-generated from the abstractA systematic review and meta-analysis of 12 studies found that mindfulness-based interventions significantly reduce depression and anxiety and improve mindfulness and quality of life in people with Parkinson's disease compared to control conditions. No statistically significant effect on motor symptoms was observed. Subgroup analyses showed that participants from Asia, those receiving face-to-face sessions, and sessions lasting 1.5 hours had more positive effects. Mindfulness-based interventions represent a promising non-pharmacological approach for improving psychological well-being and quality of life in Parkinson's disease, though their efficacy for motor symptoms remains inconclusive.
Study at a glance
| Characteristics | Systematic review and meta-analysis Peer reviewed |
|---|---|
| Population | Patients with Parkinson's disease |
| Intervention | Mindfulness-based interventions |
| Topics | Meditation |
| Keywords | Meta-analysis Parkinson’s disease Motor symptoms Psychological symptom |
| Citations | 10 |
| Key finding | Mindfulness-based interventions significantly improve depression, anxiety, mindfulness, and quality of life in Parkinson's disease patients, but do not significantly affect motor symptoms. |
Abstract
To examine the effectiveness of mindfulness-based interventions (MBIs) on psychological symptoms, motor symptoms, and quality of life in patients with Parkinson's disease (PD). Published studies in Chinese and English languages, conducted from inception to March 2023, were identified by searching PubMed, Web of Science, Cochrane Library, CINAHL, PsycINFO, and two Chinese electronic databases. The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines. Twelve studies were selected for quantitative syntheses. The impact of MBIs on reducing depression and anxiety, and improving mindfulness and quality of life in PD patients was statistically significant compared to the control group. However, no statistically significant effect on motor symptoms was observed. Subgroup analysis indicated that participants from Asia, those who received face-to-face sessions, and those whose sessions lasted 1.5 hours showed a more positive effect than other subgroups. Patients with PD may benefit from MBIs to improve psychological symptoms and quality of life. MBIs represent a pivotal non-pharmacological therapeutic approach in clinical practice. MBIs confer positive improvements in psychological well-being and quality of life in PD patients. However, it remains challenging to conclusively determine their efficacy in addressing motor symptoms.